» Articles » PMID: 34326183

Type 2 Diabetes Mellitus and Antibiotic-resistant Infections: a Systematic Review and Meta-analysis

Overview
Specialty Health Services
Date 2021 Jul 30
PMID 34326183
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Type 2 diabetes mellitus (T2DM) has been associated with infectious diseases; however, whether T2DM is associated with bacterial-resistant infections has not been thoroughly studied. We ascertained whether people with T2DM were more likely to experience resistant infections in comparison to T2DM-free individuals.

Methods: Systematic review and random-effects meta-analysis. The search was conducted in Medline, Embase and Global Health. We selected observational studies in which the outcome was resistant infections (any site), and the exposure was T2DM. We studied adult subjects who could have been selected from population-based or hospital-based studies. I was the metric of heterogeneity. We used the Newcastle-Ottawa risk of bias scale.

Results: The search retrieved 3370 reports, 97 were studied in detail and 61 (449 247 subjects) were selected. Studies were mostly cross-sectional or case-control; several infection sites were studied, but mostly urinary tract and respiratory infections. The random-effects meta-analysis revealed that people with T2DM were twofold more likely to have urinary tract (OR=2.42; 95% CI 1.83 to 3.20; I 19.1%) or respiratory (OR=2.35; 95% CI 1.49 to 3.69; I 58.1%) resistant infections. Although evidence for other infection sites was heterogeneous, they consistently suggested that T2DM was associated with resistant infections.

Conclusions: Compelling evidence suggests that people with T2DM are more likely to experience antibiotic-resistant urinary tract and respiratory infections. The evidence for other infection sites was less conclusive but pointed to the same overall conclusion. These results could guide empirical treatment for patients with T2DM and infections.

Citing Articles

Difficult-to-Treat Infections in Critically Ill Patients: A Comprehensive Review and Treatment Proposal.

Vidal-Cortes P, Campos-Fernandez S, Cuenca-Fito E, Del Rio-Carbajo L, Fernandez-Ugidos P, Lopez-Ciudad V Antibiotics (Basel). 2025; 14(2).

PMID: 40001421 PMC: 11851922. DOI: 10.3390/antibiotics14020178.


Diabetes potentiates the emergence and expansion of antibiotic resistance.

Shook J, Genito C, Darwitz B, Tyson K, Velez A, Bridwell S Sci Adv. 2025; 11(7):eads1591.

PMID: 39937900 PMC: 11817934. DOI: 10.1126/sciadv.ads1591.


Prevalence of Antimicrobial Resistance Among the WHO's AWaRe Classified Antibiotics Used to Treat Urinary Tract Infections in Diabetic Women.

Hamdan A, AbuHaweeleh M, Al-Qassem L, Kashkoul A, Alremawi I, Hussain U Antibiotics (Basel). 2025; 13(12.

PMID: 39766608 PMC: 11672800. DOI: 10.3390/antibiotics13121218.


Prevalence of Antibiotic Resistance in Older Adults and Alzheimer's Disease Patients: A Systematic Review and Meta-Analysis.

Gohil N, Gandara F, Gohil H, Gurajala S, Innocent D, Tesfaye T J Alzheimers Dis Rep. 2024; 8(1):1241-1251.

PMID: 39434821 PMC: 11491939. DOI: 10.3233/ADR-240057.


Uropathogens and their antibiotic susceptibility patterns among diabetic patients at st. john of god hospital, duayaw nkwanta, Ghana: a cross-sectional study.

Iddrisu A, Owusu G, Doe S, Yeboah A, Agyapong J, Yankey N Health Sci Rep. 2024; 7(9):e70072.

PMID: 39296635 PMC: 11409053. DOI: 10.1002/hsr2.70072.


References
1.
. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1736-1788. PMC: 6227606. DOI: 10.1016/S0140-6736(18)32203-7. View

2.
Ho H, Tan M, Chen M, Tan T, Koo S, Koong A . Interaction between Antibiotic Resistance, Resistance Genes, and Treatment Response for Urinary Tract Infections in Primary Care. J Clin Microbiol. 2019; 57(9). PMC: 6711900. DOI: 10.1128/JCM.00143-19. View

3.
Micek S, Wunderink R, Kollef M, Chen C, Rello J, Chastre J . An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance. Crit Care. 2015; 19:219. PMC: 4446947. DOI: 10.1186/s13054-015-0926-5. View

4.
Chiu C, Lin T, Wu R, Yang Y, Hsiao P, Lee Y . Etiologies of community-onset urinary tract infections requiring hospitalization and antimicrobial susceptibilities of causative microorganisms. J Microbiol Immunol Infect. 2017; 50(6):879-885. DOI: 10.1016/j.jmii.2016.08.008. View

5.
Apisarnthanarak A, Kiratisin P, Saifon P, Kitphati R, Dejsirilert S, Mundy L . Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study. Am J Infect Control. 2007; 35(9):606-12. DOI: 10.1016/j.ajic.2007.05.008. View